These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 32445412)

  • 1. Efficacy of levetiracetam in the treatment of Sydenham chorea.
    Direk M; Epcacan S; Epcacan Z; Yildirim DD; Okuyaz C
    Pediatr Int; 2020 Nov; 62(11):1264-1268. PubMed ID: 32445412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of haloperidol and valproate in children with Sydenham chorea.
    Ronchezel MV; Hilario MO; Forleo LH; Len CA; Terreri MT; Vilanova LC; Sole D
    Indian Pediatr; 1998 Dec; 35(12):1215-8. PubMed ID: 10216698
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.
    Peña J; Mora E; Cardozo J; Molina O; Montiel C
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):374-7. PubMed ID: 12131934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid in the treatment of Sydenham chorea.
    Alvarez LA; Novak G
    Pediatr Neurol; 1985; 1(5):317-9. PubMed ID: 3939747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens.
    Genel F; Arslanoglu S; Uran N; Saylan B
    Brain Dev; 2002 Mar; 24(2):73-6. PubMed ID: 11891095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on executive functions of antiepileptic monotherapy in pediatric age.
    Operto FF; Pastorino GMG; Mazza R; Carotenuto M; Roccella M; Marotta R; di Bonaventura C; Verrotti A
    Epilepsy Behav; 2020 Jan; 102():106648. PubMed ID: 31715510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exceptionally good response to sodium valproate in patients with recurrent Sydenham's chorea].
    Bouchal S; Ouali O; Belahsen MF
    Pan Afr Med J; 2017; 27():212. PubMed ID: 28979614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficiency of carbamazepine in a case of post-streptococcal hemichorea].
    Hernández-Latorre MA; Roig-Quilis M
    Rev Neurol; 2003 Aug 16-31; 37(4):322-6. PubMed ID: 14533107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Alternative Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea: Levetiracetam Efficacy in a Child.
    Şahin S; Cansu A
    Clin Neuropharmacol; 2015; 38(4):144-6. PubMed ID: 26166232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
    Yu L; Feng J; Yu Z; Dai H
    Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments and Outcomes Among Patients with Sydenham Chorea: A Meta-Analysis.
    Eyre M; Thomas T; Ferrarin E; Khamis S; Zuberi SM; Sie A; Newlove-Delgado T; Morton M; Molteni E; Dale RC; Lim M; Nosadini M;
    JAMA Netw Open; 2024 Apr; 7(4):e246792. PubMed ID: 38625703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of rheumatic chorea with carbamazepine.
    Harel L; Zecharia A; Straussberg R; Volovitz B; Amir J
    Pediatr Neurol; 2000 Aug; 23(2):147-51. PubMed ID: 11020640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary data on prednisone effectiveness in children with Sydenham chorea.
    Favaretto E; Gortani G; Simonini G; Pastore S; Di Mascio A; Cimaz R; Taddio A
    Eur J Pediatr; 2020 Jun; 179(6):993-997. PubMed ID: 31965299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Apo B100/A1 Ratio in Children With Epilepsy on Monotherapy With Sodium Valproate, Oxcarbazepine or Levetiracetam.
    Lekhwani S; Dhama A; Kaushik JS
    Indian Pediatr; 2023 Jun; 60(6):492-495. PubMed ID: 37293912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Evaluation of Levetiracetam in the Treatment of Epilepsy.
    Wu H; Liu J; Qian F; Yang J; Wang Y; Guan S
    J Healthc Eng; 2022; 2022():3789516. PubMed ID: 35422974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
    Lu PL; Hodes JF; Zheng X; Hu XY
    Intern Med; 2020 Oct; 59(20):2471-2480. PubMed ID: 32611957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.